VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial.
Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial. Cancer. 2006 Jun 01; 106(11):2309-17.
View in:
PubMed
subject areas
Breast Neoplasms
Cancer Vaccines
CD8-Positive T-Lymphocytes
Chromium
Dendritic Cells
Epitopes
Female
Humans
Ovarian Neoplasms
Peptide Fragments
Receptor, ErbB-2
Tissue Donors
T-Lymphocytes, Cytotoxic
Tumor Cells, Cultured
authors with profiles
ELIZABETH ANN MITTENDORF